Dr. Denise Faustman

Patient Leader

Denise Faustman, MD, PhD, is Director of the Immunobiology Laboratory at the Massachusetts General Hospital (MGH) and an Associate Professor of Medicine at Harvard Medical School. Her current research focuses on discovering and developing new treatments for type 1 diabetes and other autoimmune diseases. She is currently leading a human clinical trial program that is testing the efficacy of the BCG vaccine--better known for its use in tuberculosis prevention--for a new use: the reversal of long-term type 1 diabetes. The BCG vaccine is a safe, relatively inexpensive, generic drug that may be a low-cost option for improving type 1 diabetes for the many people who have been living with this disease for years. In a Phase I clinical trial, the drug temporarily restored insulin production in patients who had type 1 diabetes for an average of 15 years. A Phase II human clinical trial is currently being planned.

Past Awards Participation

Third Annual Health Activist Awards


Best Kept Secret Geek Health Activist Health Activist Hero
Dr. Denise Faustman

You Might Also Like


Best in Show: Community or Forum Nominee

Health Activist Hero Nominee

Lilly Stairs

Healthcare Collaborator: Patient Nominee

Best in Show: Podcast Nominee

Autism Warrior NY

Best in Show: Facebook Nominee

Health Activist Hero Nominee

Mitch Sturgeon

Best Kept Secret Nominee

Best Kept Secret Nominee

Bryony Isobel / chronically.b_

Best in Show: Instagram Nominee


Best in Show: Blog Nominee

Best Kept Secret Nominee

Add Your Nomination